Cargando…

Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Isoprostanes (IsoPs) are lipid peroxidation biomarkers that reveal the oxidative status of the organism without specifying which organs or tissues it occurs in. Similar compounds have recently been identified that can assess central nervous system (CNS) lipid peroxidation status, usually oxidated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Arcusa, Raúl, Carillo, Juan Ángel, Cerdá, Begoña, Durand, Thierry, Gil-Izquierdo, Ángel, Medina, Sonia, Galano, Jean-Marie, Zafrilla, María Pilar, Marhuenda, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045327/
https://www.ncbi.nlm.nih.gov/pubmed/36978969
http://dx.doi.org/10.3390/antiox12030721
_version_ 1784913576097480704
author Arcusa, Raúl
Carillo, Juan Ángel
Cerdá, Begoña
Durand, Thierry
Gil-Izquierdo, Ángel
Medina, Sonia
Galano, Jean-Marie
Zafrilla, María Pilar
Marhuenda, Javier
author_facet Arcusa, Raúl
Carillo, Juan Ángel
Cerdá, Begoña
Durand, Thierry
Gil-Izquierdo, Ángel
Medina, Sonia
Galano, Jean-Marie
Zafrilla, María Pilar
Marhuenda, Javier
author_sort Arcusa, Raúl
collection PubMed
description Isoprostanes (IsoPs) are lipid peroxidation biomarkers that reveal the oxidative status of the organism without specifying which organs or tissues it occurs in. Similar compounds have recently been identified that can assess central nervous system (CNS) lipid peroxidation status, usually oxidated by reactive oxygen species. These compounds are the neuroprostanes (NeuroPs) derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the F(2t)-dihomo-isoprotanes derived from adrenic acid (AdA). The aim of the present investigation was to evaluate whether the long-term nutraceutical consumption of high polyphenolic contents (600 mg) from fruits (such as berries) and vegetables shows efficacy against CNS lipid peroxidation in urine biomarkers. A total of 92 subjects (47 females, 45 males, age 34 ± 11 years old, weight 73.10 ± 14.29 kg, height 1.72 ± 9 cm, body mass index (BMI) 24.40 ± 3.43 kg/m(2)) completed a randomized, cross-over, double-blind study after an intervention of two periods of 16 weeks consuming either extract (EXT) or placebo (PLA) separated by a 4-week washout period. The results showed significant reductions in three AdA-derived metabolites, namely, 17-epi-17-F(2t)-dihomo-IsoPs (Δ −1.65 ng/mL; p < 0.001), 17-F(2t)-dihomo-IsoPs (Δ −0.17 ng/mL; p < 0.015), and ent-7(RS)-7-F(2t)-dihomo-IsoPs (Δ −1.97 ng/mL; p < 0.001), and one DHA-derived metabolite, namely, 4-F(4t)-NeuroP (Δ −7.94 ng/mL; p < 0.001), after EXT consumption, which was not observed after PLA consumption. These data seem to show the effectiveness of the extract for preventing CNS lipid peroxidation, as determined by measurements of oxylipins in urine through Ultra-High-Performance Liquid Chromatography triple quadrupole tandem mass spectrometry (UHPLC-QqQ-ESI-MS/MS).
format Online
Article
Text
id pubmed-10045327
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100453272023-03-29 Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Arcusa, Raúl Carillo, Juan Ángel Cerdá, Begoña Durand, Thierry Gil-Izquierdo, Ángel Medina, Sonia Galano, Jean-Marie Zafrilla, María Pilar Marhuenda, Javier Antioxidants (Basel) Article Isoprostanes (IsoPs) are lipid peroxidation biomarkers that reveal the oxidative status of the organism without specifying which organs or tissues it occurs in. Similar compounds have recently been identified that can assess central nervous system (CNS) lipid peroxidation status, usually oxidated by reactive oxygen species. These compounds are the neuroprostanes (NeuroPs) derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the F(2t)-dihomo-isoprotanes derived from adrenic acid (AdA). The aim of the present investigation was to evaluate whether the long-term nutraceutical consumption of high polyphenolic contents (600 mg) from fruits (such as berries) and vegetables shows efficacy against CNS lipid peroxidation in urine biomarkers. A total of 92 subjects (47 females, 45 males, age 34 ± 11 years old, weight 73.10 ± 14.29 kg, height 1.72 ± 9 cm, body mass index (BMI) 24.40 ± 3.43 kg/m(2)) completed a randomized, cross-over, double-blind study after an intervention of two periods of 16 weeks consuming either extract (EXT) or placebo (PLA) separated by a 4-week washout period. The results showed significant reductions in three AdA-derived metabolites, namely, 17-epi-17-F(2t)-dihomo-IsoPs (Δ −1.65 ng/mL; p < 0.001), 17-F(2t)-dihomo-IsoPs (Δ −0.17 ng/mL; p < 0.015), and ent-7(RS)-7-F(2t)-dihomo-IsoPs (Δ −1.97 ng/mL; p < 0.001), and one DHA-derived metabolite, namely, 4-F(4t)-NeuroP (Δ −7.94 ng/mL; p < 0.001), after EXT consumption, which was not observed after PLA consumption. These data seem to show the effectiveness of the extract for preventing CNS lipid peroxidation, as determined by measurements of oxylipins in urine through Ultra-High-Performance Liquid Chromatography triple quadrupole tandem mass spectrometry (UHPLC-QqQ-ESI-MS/MS). MDPI 2023-03-14 /pmc/articles/PMC10045327/ /pubmed/36978969 http://dx.doi.org/10.3390/antiox12030721 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Arcusa, Raúl
Carillo, Juan Ángel
Cerdá, Begoña
Durand, Thierry
Gil-Izquierdo, Ángel
Medina, Sonia
Galano, Jean-Marie
Zafrilla, María Pilar
Marhuenda, Javier
Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
title Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
title_full Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
title_fullStr Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
title_full_unstemmed Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
title_short Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
title_sort ability of a polyphenol-rich nutraceutical to reduce central nervous system lipid peroxidation by analysis of oxylipins in urine: a randomized, double-blind, placebo-controlled clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045327/
https://www.ncbi.nlm.nih.gov/pubmed/36978969
http://dx.doi.org/10.3390/antiox12030721
work_keys_str_mv AT arcusaraul abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT carillojuanangel abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT cerdabegona abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT durandthierry abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT gilizquierdoangel abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT medinasonia abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT galanojeanmarie abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT zafrillamariapilar abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial
AT marhuendajavier abilityofapolyphenolrichnutraceuticaltoreducecentralnervoussystemlipidperoxidationbyanalysisofoxylipinsinurinearandomizeddoubleblindplacebocontrolledclinicaltrial